Drug Search Results
More Filters [+]

Dianicline

Alternative Names: dianicline
Latest Update: 2024-05-08
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dianicline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Tobacco Use Disorder|Smoking Cessation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AMERIDIAN

P3

Completed

Tobacco Use Disorder|Smoking Cessation

2007-09-01

EURODIAN

P3

Completed

Tobacco Use Disorder

2007-06-01

Recent News Events